Home » Topics » BioWorld Science

BioWorld Science
RSS

Recent Japanese patent covers new PPARgamma response element activators

July 26, 2001

First market introduction announced for Zelmac

July 26, 2001

Titan and Novartis to conduct further trials of iloperidone prior to submission

July 26, 2001

OSI-774 to be tested in combination therapy for NSCLC

July 26, 2001

Questcor's Emitasol receives approval in the Czech Republic and Poland

July 26, 2001

Enzon begins phase II trial of Prothecan

July 26, 2001

Promising results reported from Multikine study in HPV-induced cervical dysplasia

July 26, 2001

Phase I/II clinical trials of StreptAvax commence

July 26, 2001

Binding characteristics and effects on steroid synthesis of two new PBR ligands

July 26, 2001

EpiGenesis obtains license to Genta antisense patents

July 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...